KNOW LABS, INC. (KNW) - Dilution Analysis

10-Q filing | 388.1M shares outstanding

S-1/A filing: This prospectus relates to the sale or other disposition by the selling stockholders identified herein or their transferees of up to 367,634,098 shares of common stock of USBC, Inc.

10-K filing | 2.7M shares outstanding

8-K filing: Know Labs, Inc. closed a private placement issuing 357.8 million shares of common stock, changed its name to USBC, Inc., and converted Series C and Series D preferred stock into common stock, while also redeeming Series H preferred stock for cash and common stock. ($16.0M proceeds)

10-Q filing | 7.5M shares outstanding

10-Q filing | 2.9M shares outstanding

8-K filing: Stock split 1-for-40 | Outstanding: 2,810,598 → 70,264

8-K filing: Stock split 1-for-40 | Outstanding: 108,468,489 → 2,810,598

10-Q filing | 108.5M shares outstanding

8-K filing: The Company entered into Subscription Agreements for a registered direct offering of 1,250,000 units at a price of $0.24 per Unit, each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock, for gross proceeds of $300,000. ($0.3M proceeds)

8-K filing: The Company approved the Extension of Warrant Agreement with Clayton Struve, extending the exercise dates for warrants issued on various dates in 2016, 2017, and 2018, with exercise prices of $0.25, to new expiration dates in 2030.

10-K filing | 108.1M shares outstanding

8-K filing: The company completed a registered direct offering of 6,365,385 units, each consisting of one share of common stock and one warrant, at a price of $0.26 per unit, for gross proceeds of $1,655,000 on August 15, 2024. ($1.66M proceeds)

10-Q filing | 86.4M shares outstanding

8-K filing: Know Labs, Inc. completed a public offering of 13,250,000 units, each consisting of one share of common stock and one warrant, at a price of $0.26 per unit, with Boustead Securities, LLC and The Benchmark Company, LLC acting as underwriters, and the underwriters partially exercised their over-allotment option to purchase 1,987,500 warrants. ($3.45M proceeds)

S-1/A filing: The company is offering 9,259,259 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock, at an assumed offering price of $0.432 per unit for gross proceeds of approximately $4.0 million.

S-1/A filing: This S-1/A filing relates to an offering of units, each consisting of one share of common stock and one warrant, with an assumed public offering price of $0.432 per unit. It also covers the potential issuance of additional shares and warrants upon exercise of the underwriter's over-allotment option, and the shares of common stock issuable upon the exercise of the warrants and the Representative's Unit Purchase Option.

S-1/A filing: This S-1/A filing registers 12,000,000 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock, as well as the warrants and shares of common stock issuable upon exercise of the warrants.

S-1/A filing: This S-1/A filing relates to an offering of 13,000,000 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock, as well as a unit purchase option granted to the underwriter.

S-1 filing: The filing relates to the offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock. The units have no stand-alone rights and will not be certificated or issued as stand-alone securities. The shares of common stock and the warrants comprising the units are immediately separable and will be issued separately in this offering. We are also registering the shares of common stock issuable from time to time upon exercise of the warrants included in the units offered hereby.

10-Q filing | 82.5M shares outstanding

S-1/A filing: This prospectus relates to the resale of up to 4,800,000 shares of Common Stock issuable upon conversion of a secured, convertible note and up to 6,000,000 shares of Common Stock underlying a common stock purchase warrant by the selling stockholder.

S-1 filing: This prospectus relates to the resale, from time to time, by the selling stockholder identified in this prospectus under the caption "Selling Stockholder," of up to 4,800,000 shares of Common Stock of Know Labs, Inc., a Nevada corporation (the "Company"), $0.001 par value (the "Common Stock"), which are issuable upon conversion of a secured, convertible note in the principal amount of $4,800,000 (the "Note"), at an initial conversion price of $1.00 per share, subject to adjustment, and up to 6,000,000 shares of Common Stock underlying a common stock purchase warrant (the "Warrant") at an initial exercise price of $0.80 per share.

8-K filing: Know Labs, Inc. entered into a securities purchase agreement with Lind Global Fund II, LP, issuing an initial convertible note with a principal amount of $4,800,000 in exchange for $4,000,000, convertible into shares at $1.00 per share, and a warrant to purchase up to 3,000,000 shares at $0.80 per share. ($4.0M proceeds)

10-Q filing | 81.3M shares outstanding

S-3/A filing: Know Labs, Inc. may sell common stock, preferred stock, debt securities, warrants, rights and units from time to time in one or more offerings for a total of $18,000,000.

S-3 filing: Registration statement for the potential sale of common stock, preferred stock, and debt securities for an aggregate amount of $18,000,000.

10-K filing | 80.4M shares outstanding

8-K filing: Know Labs, Inc. announces the partial exercise of the underwriter's over-allotment option, resulting in the sale of an additional 883,061 shares of common stock at $0.25 per share and the issuance of warrants to purchase 61,814 shares.

8-K filing: Know Labs, Inc. closed a public offering of 28,000,000 shares of common stock at $0.25 per share, resulting in net proceeds of approximately $6.39 million after deducting underwriting commission and expenses. ($7.0M proceeds)

S-1/A filing: This S-1/A filing relates to the offer and sale of common stock and warrants by Know Labs, Inc. pursuant to an underwriting agreement.

S-1/A filing: This S-1/A filing discusses the registration of common stock under the Exchange Act, approval for listing on the NYSE American, and a 30-day option for underwriters to purchase additional shares to cover over-allotments.

10-Q filing | 52.4M shares outstanding

10-Q filing | 48.2M shares outstanding

10-Q filing | 48.2M shares outstanding

S-3/A filing: This is an S-3/A filing for Know Labs, Inc. relating to the offering of 26,879,710 shares of common stock by selling stockholders, including shares issuable upon exercise of warrants, conversion of preferred stock, and conversion of debt.

10-K filing | 48.2M shares outstanding

S-3/A filing: This S-3/A filing describes the offering of 26,879,710 shares of common stock that may be sold from time to time by the selling stockholders.

8-K filing: The company approved amendments to senior secured convertible redeemable notes with Clayton Struve, extending the due dates to September 30, 2023, and approved the Extension of Warrant Agreement with Clayton Struve, extending the exercise dates for several warrants.

S-3/A filing: This prospectus relates to 26,879,710 shares of common stock that may be sold from time to time by the selling stockholders named in this prospectus.

S-3 filing: This prospectus relates to 26,879,710 shares of common stock that may be sold from time to time by the selling stockholders named in this prospectus.

8-K filing: Know Labs, Inc. completed a public offering of common stock on September 20, 2022, selling 4,140,000 shares at $2.00 per share, resulting in gross proceeds of approximately $8.3 million and net proceeds of approximately $7.5 million after deducting underwriting commission and expenses. ($8.3M proceeds)

S-1/A filing: This is an S-1/A filing for the registration of common stock and underwriters warrants.

S-1/A filing: This S-1/A filing includes information about the sale of common shares and representative warrants, indemnification of directors and officers, recent sales of unregistered securities, exhibits, and undertakings.

10-Q filing | 43.8M shares outstanding

S-1 filing: Firm commitment public offering of 3,000,000 shares of common stock at an estimated price of $2.00 per share.

10-Q filing | 43.7M shares outstanding

10-Q filing | 36.0M shares outstanding

10-K filing | 24.8M shares outstanding

10-Q filing | 33.7M shares outstanding

10-Q filing | 28.3M shares outstanding

10-Q filing | 26.3M shares outstanding

10-K filing | 24.8M shares outstanding

10-Q filing | 23.9M shares outstanding

S-1 filing: S-1 filing for 9,526,085 shares of common stock, including shares underlying convertible notes and warrants, with proceeds from warrant exercises used for general working capital.

10-Q filing | 23.3M shares outstanding

10-Q filing | 19.2M shares outstanding

S-1/A filing: This is an S-1/A filing for Know Labs, Inc. registering shares of common stock issuable upon conversion of notes, preferred stock and exercise of warrants.